» Authors » Hugo M van der Kuy

Hugo M van der Kuy

Explore the profile of Hugo M van der Kuy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 19
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brouwers T, Cobanoglu U, Geers D, Rietdijk W, Gommers L, Bogers S, et al.
J Sleep Res . 2024 Dec; :e14431. PMID: 39658344
Shift work can cause circadian misalignment, which often results in sleeping problems and has been associated with immune dysfunction. To better understand the impact of shift work on a primary...
2.
Linkens A, Milosevic V, van Nie N, Zwietering A, de Leeuw P, van den Akker M, et al.
BMC Geriatr . 2022 Jan; 22(1):36. PMID: 35012478
Background: Due to ageing of the population the incidence of multimorbidity and polypharmacy is rising. Polypharmacy is a risk factor for medication-related (re)admission and therefore places a significant burden on...
3.
der Holst H, Lammers G, van der Horst G, Chaves I, de Vries R, GeurtsvanKessel C, et al.
J Sleep Res . 2021 Oct; 31(2):e13496. PMID: 34617358
This protocol describes an innovative study to investigate the relationship between sleep, shift work and the immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2; coronavirus disease 2019 [COVID-19]) vaccination....
4.
Milosevic V, Linkens A, Winkens B, Hurkens K, Wong D, van Oijen B, et al.
BMJ Open . 2021 May; 11(5):e042941. PMID: 33941626
Objectives: To develop (part I) and validate (part II) an electronic fall risk clinical rule (CR) to identify nursing home residents (NH-residents) at risk for a fall incident. Design: Observational,...
5.
Sablerolles R, Hogenhuis F, Lafeber M, van de Loo B, Borgsteede S, Boersma E, et al.
Eur J Hosp Pharm . 2020 Jun; 27(4):191-193. PMID: 32587077
Various theories about drugs such as ACE inhibitors or angiotensin II receptor blockers (ARBs) in relation to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and clinical outcomes of COVID-19 are...
6.
van der Kuy H
Eur J Hosp Pharm . 2020 Jun; 27(4):189. PMID: 32587075
No abstract available.